Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...

CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Please provide your email address to receive an email when new articles are posted on . The in vitro immunoassay is being developed by Roche in partnership with Eli Lilly & Co. Blood-based biomarker ...

Glial fibrillary acidic protein (GFAP), a blood biomarker, can be used to rapidly distinguish between hemorrhagic and ischemic stroke, according to a new prospective study. The hope, researchers say, ...

Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...

The landscape of modern healthcare is undergoing a seismic shift, moving away from "one-size-fits-all" treatments toward a ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ ...

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

Data demonstrated 100% sensitivity, as early as 1-3 days post-exposure, in identifying fully vaccinated asymptomatic patients infected with COVID-19 New York, NY, and Tel Aviv, ISRAEL, Oct. 06, 2021 ...